Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Cholestasis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Cholestasis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Cholestasis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Cholestasis pipeline landscape. The report p...
April 2021
30 pages
Chordoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Chordoma (Oncology) - Drugs in Development, 2021 SUMMARY Chordoma (Oncology) - Drugs in Development, 2021 provides an overview of the Chordoma pipeline landscape. The report provides comprehensive inf...
April 2021
55 pages
Choroideremia (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Choroideremia (Ophthalmology) - Drugs in Development, 2021 SUMMARY Choroideremia (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Choroideremia pipeline landscape. The report p...
April 2021
30 pages
Chronic Cough (Respiratory) - Drugs in Development, 2021
US$ 2,000.00
Chronic Cough (Respiratory) - Drugs in Development, 2021 SUMMARY Chronic Cough (Respiratory) - Drugs in Development, 2021 provides an overview of the Chronic Cough pipeline landscape. The report provi...
April 2021
40 pages
Cirrhosis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Cirrhosis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Cirrhosis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Cirrhosis pipeline landscape. The report provide...
April 2021
35 pages
Claudin 18 (CLDN18) - Drugs in Development, 2021
US$ 3,000.00
Claudin 18 (CLDN18) - Drugs in Development, 2021 SUMMARY Claudin 18 (CLDN18) - Drugs in Development, 2021 provides in depth analysis on Claudin 18 (CLDN18) targeted pipeline therapeutics. The report p...
April 2021
35 pages
CNS Lymphoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
CNS Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY CNS Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the CNS Lymphoma pipeline landscape. The report provides compr...
April 2021
30 pages
Colon Carcinoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Colon Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Colon Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Colon Carcinoma pipeline landscape. The report provi...
April 2021
75 pages
Complement C1q Subcomponent - Drugs in Development, 2021
US$ 3,000.00
Complement C1q Subcomponent - Drugs in Development, 2021 SUMMARY Complement C1q Subcomponent - Drugs in Development, 2021 provides in depth analysis on Complement C1q Subcomponent targeted pipeline th...
April 2021
30 pages
